Treatment of refractory and relapsed Hodgkin's disease: Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support

1990 ◽  
Vol 18 (6) ◽  
pp. 447-453 ◽  
Author(s):  
David D. Hurd ◽  
Robert J. Haake ◽  
Larry C. Lasky ◽  
Neal P. Christiansen ◽  
Philip B. McGlave ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Stem Cell ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Autologous Bone Marrow ◽  
Blood Stem Cell ◽  
Intensive Chemotherapy ◽  
Stem Cell Support ◽  
Autologous Bone ◽  
Cell Support

scholarly journals Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas

Cancer ◽  
2002 ◽  
Vol 95 (6) ◽  
pp. 1354-1365 ◽  
Author(s):  
Douglas S. Hawkins ◽  
Judy Felgenhauer ◽  
Julie Park ◽  
Susan Kreissman ◽  
Blythe Thomson ◽  
...  
Keyword(s):  
Stem Cell ◽  
Children And Adolescents ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Blood Stem Cell ◽  
Intensive Chemotherapy ◽  
Stem Cell Support ◽  
Cell Support

scholarly journals A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis

Cancer ◽  
2004 ◽  
Vol 101 (1) ◽  
pp. 156-163 ◽  
Author(s):  
Shreyaskumar R. Patel ◽  
Nicholas Papadopolous ◽  
A. Kevin Raymond ◽  
Michele Donato ◽  
Chu-Myong Seong ◽  
...  
Keyword(s):  
Stem Cell ◽  
Phase Ii ◽  
Peripheral Blood ◽  
Poor Prognosis ◽  
Bone Tumors ◽  
Peripheral Blood Stem Cell ◽  
Phase Ii Study ◽  
Blood Stem Cell ◽  
Stem Cell Support ◽  
Cell Support
Sign in / Sign up

Export Citation Format

Share Document